BNP Paribas Financial Markets Raises Stock Holdings in MeiraGTx Holdings plc (NASDAQ:MGTX)

BNP Paribas Financial Markets raised its stake in MeiraGTx Holdings plc (NASDAQ:MGTX) by 142.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,319 shares of the company’s stock after purchasing an additional 5,476 shares during the period. BNP Paribas Financial Markets’ holdings in MeiraGTx were worth $39,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the company. Royce & Associates LP boosted its holdings in shares of MeiraGTx by 5.3% in the 3rd quarter. Royce & Associates LP now owns 795,392 shares of the company’s stock valued at $3,317,000 after buying an additional 40,000 shares in the last quarter. Privium Fund Management B.V. boosted its stake in MeiraGTx by 4.9% in the third quarter. Privium Fund Management B.V. now owns 213,960 shares of the company’s stock valued at $892,000 after acquiring an additional 10,000 shares in the last quarter. China Universal Asset Management Co. Ltd. grew its holdings in MeiraGTx by 97.0% in the third quarter. China Universal Asset Management Co. Ltd. now owns 14,886 shares of the company’s stock worth $62,000 after purchasing an additional 7,330 shares during the last quarter. SG Americas Securities LLC purchased a new position in MeiraGTx in the third quarter worth $82,000. Finally, SkyView Investment Advisors LLC acquired a new position in shares of MeiraGTx during the second quarter worth $126,000. 67.48% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Chardan Capital reissued a “buy” rating and issued a $36.00 price objective on shares of MeiraGTx in a research report on Monday, November 18th. Royal Bank of Canada raised their price target on MeiraGTx from $9.00 to $11.00 and gave the stock an “outperform” rating in a report on Thursday, November 14th.

MeiraGTx Stock Performance

NASDAQ MGTX opened at $5.84 on Friday. MeiraGTx Holdings plc has a 12-month low of $3.85 and a 12-month high of $7.60. The company has a fifty day simple moving average of $6.12 and a two-hundred day simple moving average of $4.96. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.86. The stock has a market cap of $456.41 million, a P/E ratio of -4.83 and a beta of 1.25.

MeiraGTx Company Profile

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.